Page 39 - GPD-3-4
P. 39

Gene & Protein in Disease                                                      Buccal mucosa and aging



                                                                 Moreover, changes in biomarkers related to NK cells,
                                                               such as cytokines, including interferon (IFN)-γ, IFN-β,
                                                               and interleukins (IL-2), as well as alterations in NK cell
                                                               types, are associated with aging. NK cells may also exhibit
                                                               telomere shortening, a marker of aging,  which can be
                                                                                                70
                                                               investigated using buccal cells. This approach enhances
                                                               our understanding of aging and age-related diseases
                                                               and aids in designing future immune therapies targeting
                                                               NK cells in the elderly population.  Identifying reliable
                                                                                            69
                                                               biomarkers is crucial for accurate risk stratification and
                                                               exploring antiaging interventions.  Given the challenge of
                                                                                          3
                                                               pinpointing a single biomarker that reflects the intricate
                                                               interaction between environmental exposures and
                                                               aging, further studies are needed to identify biomarkers
            Figure 3. Biomarkers associated with environmental exposure
                                                               sensitive to mixed or low-dose exposures. In addition, a
                                                               combination of biomarkers reflecting various levels of
            exposures. 24,82,83  These biomarkers indicate short-term   cellular organization, such as DNA, RNA, and proteins,
            DNA or chromosomal damage in cytogenetic analyses    may provide the most effective approach.
                                                         30
            and serve as sensitive indicators of recent human
            exposures to hazards.  Consequently, the potential risk   6. Interaction between molecular
                              84
            posed by hazards and their ability to induce long-term   biomarkers and aging
            health problems can be determined.  Biomarkers of effect
                                         30
            show early health effects, such as health impairment and   Genomic damages after exposure to chemicals can occur
            critical and clinical effects. 24,82,83  Biomonitoring the effects   in two forms: (i) point mutations at the nucleotide level in
            of exposure through various cytogenetic tests enables the   a gene and (ii) structural changes in chromosomes, such
                                                                                       90
            evaluation of genotoxic effects by detecting DNA damage,   as chromosomal aberrations.  Two major perspectives
                                                               on senescence include: (i) a specific genetic program
            such as  sister chromatid  exchange and micronuclei.    for senescence and (ii) evolutionary forces, particularly
                                                         46
            Micronuclei, an example of such biomarkers,  are formed
                                                84
            due to chromosomal damage,  typically arising from   reproductive success, that suggest a genetic basis for
                                      85
                                                                        58
            chromosomal fragmentation or lagging.  This biomarker   senescence.  Senescence results from the coordinated
                                            86
            is evaluated in cells, such as buccal cells, and reflects   actions of multiple genes, and mutations in these genes can
                                                                                  67
            genotoxic damage in the dividing basal cell layer of target   lead to premature aging.
                                  46
            organs 1 – 3 weeks earlier.  Micronucleus levels tend to   Genetic analysis of aging helps identify regulatory links
            increase with age.  The first effective biomarkers used to   between gene expressions and lifespan,  involving pathways
                                                                                             91
                          86
            assess the aging process were micronuclei, sister chromatid   such as insulin/IGF-1 signaling, PI3K, TOR, MAPK,
            exchange, and chromosome aberrations. 77           AMPK, PKC, NF-κb, TGF-β, Notch, WNT, S6K, 92-96  and the
                                                                                               64
              Biomarkers of susceptibility indicate an individual’s   p53/p21 and p16INK4A/pRb pathways.  The p16INK4A/
            increased sensitivity to specific target molecules or   pRb pathway can lead to premature senescence or stress-
            metabolic processes, leading to a higher dose of the target   induced  premature  senescence.  Oncogene-induced
            compound upon exposure. 24,82,83  These biomarkers reveal   senescence is characterized by the activation of pathways
            the  inherent  or  acquired  capability of  an organism to   involving p53 and DNA damage and is marked by tumor
                                                                                                        64
            metabolize xenobiotic substances upon chemical exposure,   progression restriction without telomere shortening.
            resulting  in  variations  in  metabolic  pathways  and  toxic   DNA repair pathways play an important role in
            responses among individuals. Examples of susceptibility   correcting  damage  caused  by  mutagens,  such  as  DNA
            biomarkers include cytochrome P-450 (CYPs) and     damage  and chromosomal alterations,  which pose
                                                                                                 79
                                                                     73
            glutathione transferases (GSTs).  Telomere shortening and   significant threats to living cells. These repair processes
                                     87
            epigenetic modifications are also included in this group.    involve cell cycle regulation  and mechanisms such as
                                                         88
                                                                                      97
            Epigenetic biomarkers reflect stable changes to the genome   the SOS response,  utilizing ATP and NADH to remove
                                                                             76
                                             3,89
            that affect gene expression or silencing.  Factors such   DNA  lesions.   It  is  estimated  that  over  130  genes  in  the
                                                                          62
                                                                                                   98
            as  DNA  methylation  levels,  cell  metabolism,  and  signal   human genome are involved in DNA repair,  with more
            transmission control through epigenetic mechanisms play   than 70 genes contributing directly to the major nuclear
            significant roles in human longevity. 68           DNA repair pathways.  Mutations in these repair genes
                                                                                 99
            Volume 3 Issue 4 (2024)                         5                               doi: 10.36922/gpd.4418
   34   35   36   37   38   39   40   41   42   43   44